Advertisement

Die therapeutische Wirksamkeit von Dopamin beim akuten Nierenversagen

  • B. Mühlbauer

Zusammenfassung

Die therapeutische Wirksamkeit eines Arzneimittels gilt als erwiesen, wenn seine erwünschten pharmakodynamischen Effekte in einem sinnvollen und kalkulierbaren Verhältnis zu den möglichen unerwünschten Wirkungen stehen. Erst der Nachweis einer günstigen Beeinflussung des Krankheitsverlaufes macht das Medikament zum Werkzeug einer rationalen Arzneimitteltherapie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderson RJ, Schrier RW (1988) Acute tubular necrosis. In: (Hrsg) Schrier RW, Gottschalk CW. Diseases of the kidney. Little, Brown, Boston, S 1413–1446Google Scholar
  2. 2.
    Aperia A, Bertorello A, Seri I (1987) Dopamine causes inhibition of Na, K-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252:F39–39F45Google Scholar
  3. 3.
    Baines AD, Drangova R (1984) Dopamine production by the isolated perfused rat kidney. Can J Physiol Pharmacol 62:272–276PubMedCrossRefGoogle Scholar
  4. 4.
    Baldwin L, Henderson A, Hickman P (1994) Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744–747PubMedGoogle Scholar
  5. 5.
    Ball SG, Gunn IG, Douglas IH (1982) Renal handling of dopa, dopamine, norepinephrine, and epinephrine in the dog. Am J Physiol 242:F56–56F62Google Scholar
  6. 6.
    Barger G, Ewins AJ (1910) Some phenolic derivatives of phenylalanine. J Chem Soc 97:2263–2261Google Scholar
  7. 7.
    Bartholini G, Zivkovic B, Scatton B (1989) Dopaminergic neurons: basic aspects. In: Trendelenburg U, Weiner N (Hrsg) Handbook of Experimental Pharmacology: Catecholamines II. Springer, Berlin Heidelberg New York, S 277–318Google Scholar
  8. 8.
    Chertow GM, Lazarus JM, Sayegh MH, Allgren RL (1995) Is the administration of dopamine associated with adverse outcomes in severe renal failure?. J Am Soc Nephrol 6:460 (Abstract)Google Scholar
  9. 9.
    Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G (1990) Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothor Anesth 4:469–473CrossRefGoogle Scholar
  10. 10.
    Dasta JF, Kirby MG (1986) Pharmacology and therapeutic use of low-dose dopamine. Pharmacotherapy 6:304–310PubMedGoogle Scholar
  11. 11.
    Felder CC, Campbell T, Albrecht F, Jose PA (1990) Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 259:F297–297F303Google Scholar
  12. 12.
    Flancbaum L, Choban PS, Dasta JF (1994) Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 22:61–68PubMedGoogle Scholar
  13. 13.
    Giraud GD, MacCannell KL (1984) Decreased nutrient blood flow during dopamine-and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 230:214–220PubMedGoogle Scholar
  14. 14.
    Goldberg LI, Kohli JD (1983) Peripheral dopamine receptors: A classification based on potency series and specific antagonism. Trends Pharmacol Sci 4(2):64–66CrossRefGoogle Scholar
  15. 15.
    Greene SI, Smith JW. (1976) Dopamine gangrene. N Engl J Med 294: 114PubMedCrossRefGoogle Scholar
  16. 16.
    Hayashi M, Yamaji Y, Kitajima W, Sanita T (1990) Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 258:F28–F33PubMedGoogle Scholar
  17. 17.
    Hilberman M, Maseda J, Stinson EB, Derby GC, Spencer RJ, Miller DC, Oyer PE, Myers BD (1984) The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology 61: 489–494PubMedCrossRefGoogle Scholar
  18. 18.
    Hoffman BB, Lefkowitz RJ (1990) Catecholamines and sympathomimetic drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg) The pharmacological basis of therapeutics. Pergamon Press, New York, S 187–220Google Scholar
  19. 19.
    Holtz P, Credner K (1942) Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase. Naunyn-Schmiedeberg’s Arch Pharmacol 200: 356–388CrossRefGoogle Scholar
  20. 20.
    Itskovitz HD, Chen YH, Stier CTJ (1988) Reciprocal renal effects of dopamine and 5-hydroxytryptamine formed within the rat kidney. Clin Sci 75: 503–507PubMedGoogle Scholar
  21. 21.
    Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96PubMedCrossRefGoogle Scholar
  22. 22.
    Kleinknecht D (1992) Management of acute renal failure. In: Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E (Hrsg) Oxford Textbook of Clinical Nephrology. Oxford Medical Publications, Oxford, S 1015–1026Google Scholar
  23. 23.
    Le Corre P, Malledant Y, Tanguy M, Le Verge R (1993) Steady-state pharmacokinetics of dopamine in adult patients. Crit Care Med 21:1652–1657PubMedCrossRefGoogle Scholar
  24. 24.
    Lee MR. (1993) Dopamine and the kidney: 10 years on. Clin Sci 84:357–375PubMedGoogle Scholar
  25. 25.
    Lokhandwala MF, Amenta F (1991) Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 5:3023–3030PubMedGoogle Scholar
  26. 26.
    Mannich C, Jacobsohn W (1910) Über Oxyphenylalkylamine und Diophe-nylalkylamine. Ber Dtsch Chem Ges 43:189–193CrossRefGoogle Scholar
  27. 27.
    Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354–1357PubMedCrossRefGoogle Scholar
  28. 28.
    Memoli B, Libetta C, Conte G, Andreucci VE (1994) Loop diuretics and renal vasodilators in acute renal failure. Nephrol Dial Transplant 9 Suppl 4: 168–171PubMedGoogle Scholar
  29. 29.
    Meyer MB, McNay JL, Goldberg LI (1967) Effects of dopamine on renal function and hemodynamics in the dog. J Pharmacol Exp Ther 156: 186–192PubMedGoogle Scholar
  30. 30.
    Mühlbauer B, Hartenburg E, Osswald H (1994) Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazi-de. Naunyn-Schmiedeberg’s Arch Pharmacol 349: 244–249CrossRefGoogle Scholar
  31. 31.
    Mühlbauer B, Osswald H (1992) Feeding but not salt loading is the dominant factor controlling urinary dopamine excretion in conscious rats. Naunyn-Schmiedeberg’s Arch Pharmacol 346:469–471CrossRefGoogle Scholar
  32. 32.
    Mühlbauer B, Osswald H (1994) Feeding-induced increase in urinary dopamine excretion is independent of renal innervation and sodium intake. Am J Physiol 266:F563–563F567Google Scholar
  33. 33.
    Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM (1993) Effect of „renal-dose“ dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21: 56–61PubMedGoogle Scholar
  34. 34.
    Orme ML, Breckenridge A, Dollery CT (1973) The effects of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol 6:150–155PubMedCrossRefGoogle Scholar
  35. 35.
    Padbury JF, Agata Y, Baylen BG, Ludlow JK, Polk DH, Goldblatt E, Pescetti J (1987) Dopamine pharmacokinetics in critically ill newborn infants. J Pediatr 110:293–298PubMedCrossRefGoogle Scholar
  36. 36.
    Parks RW, Diamond T, McCrory DC, Johnston GW, Rowlands BJ (1994) Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br J Surg 81:437–439PubMedCrossRefGoogle Scholar
  37. 37.
    Petrides PE (1990) Nervengewebe. In: Löffler G, Petrides P (Hrsg) Physiologische Chemie. Springer, Berlin Heidelberg New York, S 909–926Google Scholar
  38. 38.
    Poison RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R (1987) The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia 42:15–19CrossRefGoogle Scholar
  39. 39.
    Puschett JB, Winaver J (1992) Effects of diuretics on renal function. In: Windhager EE (Hrsg) Handbook of Physiology (8): Renal Physiology. Oxford University Press, New York, S 2335–2406Google Scholar
  40. 40.
    Ratcliffe PJ (1992) Pathophysiology of acute renal failure. In: Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E (Hrsg) Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, S 982–1005Google Scholar
  41. 41.
    Reinsberg J, Kullmann R (1986) Characterization of vascular dopamine receptors in the gastric circulation of the rabbit. J Cardiovasc Pharmacol 8: 1067–1073PubMedCrossRefGoogle Scholar
  42. 42.
    Rump LC, Schwertfeger E, Schuster MJ, Schaible U, Frankenschmidt A, Schollmeyer PJ (1993) Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int 43:197–204PubMedCrossRefGoogle Scholar
  43. 43.
    Schwartz LB, Gewertz BL. (1988) The renal response to low dose dopamine. J Surg Res 45: 574–588PubMedCrossRefGoogle Scholar
  44. 44.
    Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313PubMedGoogle Scholar
  45. 45.
    Seeman P, Van Tol HH (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264–270PubMedCrossRefGoogle Scholar
  46. 46.
    Sumikawa K, Hayashi Y, Yamatodani A, Yoshiya I. (1991) Contribution of the lungs to the clearance of exogenous dopamine in humans. Anesth Analg 72:622–626PubMedCrossRefGoogle Scholar
  47. 47.
    Swygert TH, Roberts LC, Valek TR, Brajtbord D, Brown MR, Gunning TC, Paulsen AW, Ramsay MA (1991) Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 75:571–576PubMedCrossRefGoogle Scholar
  48. 48.
    Thompson BT, Cockrill BA. (1994) Renal-dose dopamine: a siren song? Lancet 344:7–8PubMedCrossRefGoogle Scholar
  49. 49.
    Toda N (1983) Dopamine vasodilates human cerebral artery. Experientia 39: 1131–1132PubMedCrossRefGoogle Scholar
  50. 50.
    Watson S, Girdlestone D. (1993) Receptor Nomenclature Supplement: Dopamine receptors. Trends Pharmacol Sci 14 (suppl): 13Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • B. Mühlbauer
    • 1
  1. 1.Pharmakologisches Institut der Universität TübingenTübingenGermany

Personalised recommendations